Rapid HPLC-MS/MS method for simultaneous quantitation of four routinely administered triazole antifungals in human plasma

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 240-245

  Beste, Kerstin Yvonne ^a   Burkhardt, Olaf ^a   Kaever, Volkhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Fluconazole; High performance liquid chromatography; Itraconazole; Posaconazole; Tandem mass spectrometry; Voriconazole

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; VORICONAZOLE;

ARTICLE; BLOOD LEVEL; CASE REPORT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG STABILITY; FLOW RATE; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; QUALITY CONTROL; SOLID PHASE EXTRACTION; SYSTEMIC MYCOSIS; TANDEM MASS SPECTROMETRY; TEMPERATURE; VALIDATION PROCESS;

ANTIFUNGAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIMIT OF DETECTION; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TRIAZOLES;

EID: 82955212869     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.09.042     Document Type: Article

References (33)

1. Smith J., Andes D. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther Drug Monit 2008, 3:167-172.
2. Hope W.W., Billaud E.M., Lestner J., Denning D.W. Therapeutic drug monitoring for triazoles. Curr Opin Inf Dis 2008, 21:580-586.
3. Rex J.H., Pfaller M.A., Galgiani J.N., et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Inf Dis 1997, 24:235-247.
4. Poirier J.M., Cheymol G. Optimization of itraconazole therapy using target drug concentrations. Clin Pharm 1998, 35:461-473.
5. Glasmacher A., Hahn C., Molitor E., Marklein G., Sauerbruch T., Schmidt-Wolf I.G. Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules. Mycoses 1999, 42:591-600.
6. Ueda K., Nannya Y., Kumano K., et al. Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders. Int J Hematol 2009, 89:592-599.
7. Alffenaar J.W., de Vos T., Uges D.R., Daenen S.M. High voriconazole trough levels in relation to hepatic function: how to adjust the dosage?. Br J Clin Pharm 2009, 67:262-263.
8. Kratzer C., Graninger W., Macfelda K., Buxbaum A., Georgopoulos A. Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae. Wien Klin Wochenschrift 2007, 119:297-302.
9. Wu D., Wade K.C., Paul D.J., Barrett J.S. A rapid and sensitive LC-MS/MS method for determination of fluconazole in human plasma and its application in infants with Candida infections. Ther Drug Monit 2009, 31:703-709.
10. Rhim S.Y., Park J.H., Park Y.S., et al. A sensitive validated LC-MS/MS method for quantification of itraconazole in human plasma for pharmacokinetic and bioequivalence study in 24 Korean volunteers. Pharmazie 2009, 64:1-75.
11. Grabowski T., Swierczewska A., Borucka B., Sawicka R., Sasinowska-Motyl M., Gumułka S.W. Chromatographic/mass spectrometric method for the estimation of itraconazole and its metabolite in human plasma. Application to a bioequivalence study. Arzneimittelforschung 2009, 59:422-428.
12. Vogeser M., Schiel X., Spöhrer U. Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2005, 43:730-734.
13. Cunliffe J.M., Noren C.F., Hayes R.N., Clement R.P., Shen J.X. A high-throughput LC-MS/MS method for the quantitation of posaconazole in human plasma: implementing fused core silica liquid chromatography. J Pharm Biomed Anal 2009, 50:46-52.
14. Xiong X., Duan J., Zhai S., Wang L., Lan X. Fast and reliable determination of voriconazole in human plasma by LC-APCI-MS/MS. Biosci Biotechnol Biochem 2010, 74:2151-2153.
15. Alffenaar J.W., Wessels A.M., van Hateren K., Greijdanus B., Kosterink J.G., Uges D.R. Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS. J Chromatogr B Technol Biomed Life Sci 2010, 878:39-44.
16. Chahbouni A., Wilhelm A.J., den Burger J.C., Sinjewel A., Vos R.M. Validated liquid chromatography-tandem mass spectroscopy method for the simultaneous quantification of four antimycotic agents in human serum. Ther Drug Monit 2010, 32:453-457.
17. Verdier M.C., Bentué-Ferrer D., Tribut O., Bellissant E. Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma. Clin Chem Lab Med 2010, 48:1515-1522.
18. Baietto L., D'Avolio A., Ventimiglia G., et al. Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma. Antimicrob Agent Chem 2010, 54:3408-3413.
19. Decosterd L.A., Rochat B., Pesse B., et al. Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin. Antimicrob Agents Chemother 2010, 54:5303-5315.
20. Guidance for Industry Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug administration http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
21. Mathew B.P., Nath M. Recent approaches to antifungal therapy for invasive mycoses. ChemMedChem 2009, 4:310-323.
22. Ekiert R.J., Krzek J., Talik P. Chromatographic and electrophoretic techniques used in the analysis of triazole antifungal agents-a review. Talanta 2010, 82:1090-1100.
23. Worth L.J., Blyth C.C., Booth D.L., et al. Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders. Intern Med J 2008, 38:521-537.
24. Michael C., Bierbach U., Frenzel K., et al. Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients. Antimicrob Agents Chemother 2010, 54:3225-3232.
25. Shima H., Miharu M., Osumi T., Takahashi T., Shimada H. Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3years of age. Pediatr Blood Cancer 2010, 54:1050-1052.
26. Moton A., Krishna G., Ma L., et al. Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment. Curr Med Res Opin 2010, 26:1-7.
27. Conte J.E., DeVoe C., Little E., Golden J.A. Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients. Antimicrob Agents Chemother 2010, 54:3609-3613.
28. Tapaninen T., Backman J.T., Kurkinen K., Neuvonen P.J., Niemi M. Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren. J Clin Pharmacol 2010, 51:359-367.
29. Saari T.I., Grönlund J., Hagelberg N.M., et al. Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone. Eur J Clin Pharmacol 2010, 66:387-397.
30. Wakeham K., Parkes-Ratanshi R., Watson V., Ggayi A.B., Khoo S., Lalloo D.G. Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans. J Antimicrob Chemother 2010, 65:316-319.
31. Kirchherr H., Kühn-Velten W.N. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B Technol Biomed Life Sci 2006, 843:100-113.
32. Keevil B.G., Newman S., Lockhart S., Wang L., Lan X. Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2004, 2:650-657.
33. Herbrecht R. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract 2004, 58:612-624.